Back to search

Article

Targeting Lysosomal MCOLN1/TRPML1 Ion Channels to Finely Alleviate Diabetes Mellitus via a Ca <sup>2+</sup> - CaMKKβ-AMPK pathway

2026-06-16

Abstract excerpt

Type 2 Diabetes mellitus (T2DM) is a metabolic syndrome characterized by hyperglycemia and various complications. Current drugs are limited by side effects and resistance, necessitating novel targets and therapies. Previous studies have shown that MK-83, a synthetic agonist of transient receptor potential mucolipin 1 (TRPML1/ MCOLN1), a lysosomal Ca 2+ channel, activates adenosine 5′-monophosphate-activated prote...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
bb4d19d6-e70f-5de0-a414-5b40ebc24fc7
DOI
10.64898/2026.06.16.732532
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Targeting Lysosomal MCOLN1/TRPML1 Ion Channels to Finely Alleviate Diabetes Mellitus via a Ca <sup>2+</sup> - CaMKKβ-AMPK pathwayDOI 10.64898/2026.06.16.732532
Select a neighboring publication to make it the new centre.